X4 Pharmaceuticals Inc. (XFOR)
NASDAQ · Healthcare
X4 Pharmaceuticals Inc. Total Liabilities 2018–2025
X4 Pharmaceuticals Inc. annual total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- X4 Pharmaceuticals Inc. total liabilities as of December 31, 2025: 104.2M, a 16.19% decrease year-over-year.
- X4 Pharmaceuticals Inc. total liabilities for 2025 were 104.2M, a 16.19% decrease from 2024.
- X4 Pharmaceuticals Inc. total liabilities for 2024 were 124.3M, a 29.26% increase from 2023.
- X4 Pharmaceuticals Inc. total liabilities for 2023 were 96.2M, a 17.94% increase from 2022.
- X4 Pharmaceuticals Inc. total liabilities for 2022 were 81.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| X4 Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $104 |
| 2024 | $124 |
| 2023 | $96 |
| 2022 | $82 |
| 2021 | $53 |
| 2020 | $50 |
| 2019 | $31 |
| 2018 | $22 |
X4 Pharmaceuticals Inc. Total Liabilities — FAQ
X4 Pharmaceuticals Inc. (XFOR) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XFOR's total liabilities history?
The chart and table above show X4 Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.